Skip to main content

Research Repository

Advanced Search

Consequences of late-stage non-small cell lung cancer cachexia on muscle metabolic processes

Murton, Andrew J.; Maddocks, Matthew; Stephens, Francis B.; Marimuthu, Kanagaraj; England, Ruth; Wilcock, Andrew

Consequences of late-stage non-small cell lung cancer cachexia on muscle metabolic processes Thumbnail


Authors

Andrew J. Murton

Matthew Maddocks

Francis B. Stephens

Kanagaraj Marimuthu

Ruth England

Andrew Wilcock



Abstract

Introduction: Loss of muscle is common in patients with advanced non-small cell lung cancer (NSCLC), and contributes to the high morbidity and mortality of this group. The exact mechanisms behind the loss of muscle are unclear.
Patients and methods: To investigate this, 4 patients with stage IV NSCLC meeting the clinical definitions for sarcopenia and cachexia were recruited, along with 4 age-matched healthy volunteers. Following an overnight fast, biopsies were obtained from the vastus lateralis and key components associated with inflammation and the control of muscle protein, carbohydrate and fat metabolism assessed.
Results: Compared to healthy volunteers, significant increases in mRNA levels for interleukin-6 and NF?B signalling were observed in NSCLC patients along with lower intramyocellular lipid content in slow-twitch fibres. While a significant decrease in phosphorylation of mTOR signalling protein 4E-BP1 (Ser65) was observed along with a trend towards reduced p70 S6K (Thr389) phosphorylation (P=0.06), there was no difference between groups for mRNA levels of MAFbx and MuRF1, chymotrypsin-like activity of the proteasome, or protein levels of multiple proteasome subunits. Moreover, despite decreases in intramyocellular lipid content, no robust changes in mRNA levels for key proteins involved in insulin signalling, glycolysis, oxidative metabolism or fat metabolism were observed.

Conclusions: These findings suggest that an examination of the contribution of suppressed mTOR signalling in the loss of muscle mass in late-stage NSCLC patients is warranted and reinforces our need to understand the potential contribution of impaired fat metabolism and muscle protein synthesis in the aetiology of cancer cachexia.

Journal Article Type Article
Acceptance Date Jun 13, 2016
Online Publication Date Jun 25, 2016
Deposit Date Aug 12, 2016
Publicly Available Date Aug 12, 2016
Journal Clinical Lung Cancer
Print ISSN 1525-7304
Electronic ISSN 1525-7304
Publisher Elsevier
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1016/j.cllc.2016.06.003
Keywords Muscle protein synthesis; proteolysis; cachexia; mTOR signalling; ubiquitin proteasome system
Public URL https://nottingham-repository.worktribe.com/output/793551
Publisher URL http://www.sciencedirect.com/science/article/pii/S1525730416301437

Files





Downloadable Citations